InfuSystem Holdings (INFU) Cash from Operations (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Cash from Operations came in at 970000.0 in Q1 2026, down 45.51% YoY from 1780000.0 in Q1 2025, and down 86.39% on a QoQ basis from 7126000.0 in Q4 2025.
InfuSystem Holdings (INFU) Cash from Operations (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Cash from Operations data on file, last reported at 970000.0 in Q1 2026.
- Quarterly Cash from Operations fell 45.51% year-over-year to 970000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 23598000.0 (up 7.94% YoY) and the FY2025 annual result came in at 24408000.0, up 19.3% from the prior year.
- Cash from Operations declined to 970000.0 in Q1 2026, from 7126000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 9842000.0 in Q3 2024 to a low of 151000.0 in Q1 2023.
- A 5-year average of 4386882.35 and a median of 4264000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations plunged 103.7% — and 2025, when it soared 372.15%.
- Tracing INFU's Cash from Operations over 5 years: stood at 4566000.0 in 2022, then advanced by 2.01% to 4658000.0 in 2023, then surged by 70.27% to 7931000.0 in 2024, then slipped by 10.15% to 7126000.0 in 2025, then tumbled by 86.39% to 970000.0 in 2026.
- The last three Cash from Operations figures came in at 970000.0 (Q1 2026), 7126000.0 (Q4 2025), and 8493000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 367.10 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn | 6.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.78 Mn |
| Jun 30, 2026 | 6.78 Mn |
| Mar 31, 2026 | 970,000.00 |
| Mar 31, 2026 | 970,000.00 |
| Dec 31, 2025 | 7.13 Mn |
| Dec 31, 2025 | 7.13 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 7.93 Mn |
| Dec 31, 2024 | 7.93 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 377,000.00 |
| Mar 31, 2024 | 377,000.00 |